BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38377439)

  • 1. Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca
    Guo Z; Gao X; Lu J; Li Y; Jin Z; Fahad A; Pambe NU; Ejima H; Sun X; Wang X; Xie W; Zhang G; Zhao L
    ACS Nano; 2024 Mar; 18(9):6975-6989. PubMed ID: 38377439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
    Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
    Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ generation of copper(Ⅱ)/diethyldithiocarbamate complex through tannic acid/copper(Ⅱ) network coated hollow mesoporous silica for enhanced cancer chemodynamic therapy.
    Zhu Y; Wang N; Ling J; Yang L; Omer AM; Ouyang XK; Yang G
    J Colloid Interface Sci; 2024 Apr; 660():637-646. PubMed ID: 38266345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions.
    Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L
    Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
    Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
    J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cascade nanoplatform for the regulation of the tumor microenvironment and combined cancer therapy.
    Hu X; Zhao W; Li R; Chai K; Shang F; Shi S; Dong C
    Nanoscale; 2023 Oct; 15(40):16314-16322. PubMed ID: 37786260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
    Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
    Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
    Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
    Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
    Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
    Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
    Rieber M
    Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
    Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
    Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
    Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
    Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.